![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Primär beidseitiges, adrenales, hochmalignes B-Zell-Lymphom mit Meningiosis lymphoblastica
A 64-year-old man with high malignant B-cell lymphoma in both adrenal glands was investigated. Adrenal insufficiency was his predominant symptom at presentation. Despite surgical resection of the malignancy an...
-
Chapter and Conference Paper
Adult AML: The Role of Chemotherapy Intensity and Duration. Two Studies of the AML Cooperative Group
Further improvement of chemotherapy for acute myeloid leukemia (AML) requires an evaluation of alternative treatment strategies as investigated in adequate prospective multicenter trials. Since no superior new...
-
Chapter and Conference Paper
First Experiences with a Permanent Catheter System in Acute Leukemia
To reduce complications due to central venous catheterization in the treatment of acute leukemia, we began to implant permanent catheter systems in adult patients suffering from various hematological diseases,...
-
Chapter and Conference Paper
Risk Groups in Adult Acute Lymphoblastic Leukemia
When the German multicenter trial for the treatment of adult acute lymphoblastic leukemia (ALL) and acute undifferentiated leukemia (AUL) was started in 1978, one of the main objectives was to establish progno...
-
Chapter and Conference Paper
Postinduction and Preremission Chemotherapy Alternatives for Adult AML: Three Multicenter Studies of the AML Cooperative Group
Various intensive induction regimens for adult AML involving a total of 3380 patients produced a median of 60% complete remissions (CR) ranging from 47% to 72% in multicenter [2, 4, 8, 10–12, 14] and major mon...
-
Article
Karnofsky-adapted chemotherapy of non small cell lung cancer (NSCLC) with ifosfamide/mitomycin C/vindesine
-
Article
First expirience with DDP in combination with 5-FU/VP 16 as continous venous infusion
-
Chapter and Conference Paper
Hämatologie/Onkologie
Kolonienstimulierende Faktoren („Colony Stimulating Factors, CSF“) stimulieren in vitro das Wachstum von myeloisch determinierten Stammzellen („Colony Forming Units, CFUC“). Von den Blutzellen sind es ausschließl...